Bioregenx, Inc. (BRGX): Cash & Equivalents
$58.4K
As of 2024-12-31
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $58.4K | -53.4% | 2025-04-16, Balance as of period end |
| 2023-12-31 | $125.4K | n/a | 2025-04-16, Balance as of period end |
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $58.4K | -53.4% | 2025-04-16, Balance as of period end |
| 2023-12-31 | $125.4K | n/a | 2025-04-16, Balance as of period end |